US 12138312
Cell-penetrating peptides for antisense delivery
granted A61KA61K31/713A61K38/00
Quick answer
US patent 12138312 (Cell-penetrating peptides for antisense delivery) held by Sarepta Therapeutics, Inc. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/713, A61K38/00, A61K47/645, A61K47/6455